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CASE PRESENTATION
A 35-year-old man was in good health condition until 
he experienced coughing with bloody sputum for 4 months, 
accompanied by inspiratory dyspnea for 2 months. Spiral com-
puted tomography (CT) with three-dimensional reconstruc-
tion showed stenosis in the left main bronchus. Bronchoscopy 
revealed a polypoid neoplasm in the lateral wall of the proxi-
mal left main bronchus, at the size of 1.5 3 2.0 cm, with a 
hyperemic overlying mucosa (Fig. 1). Histologic examination 
revealed numerous capillaries arranged in a lobular pattern, 
occasionally surrounded by a heaped-up collar of normal tis-
sue. These lesions, however, were altered by secondary inflam-
matory changes (Fig. 2).
Disease was not controlled after nine repetitions of 
tracheal endoscopic electrocautery and argon plasma coagu-
lation. After that, the patient underwent endotracheal high-
dose rate brachytherapy (Fig. 3) three times.The total dose 
of brachytherapy was 18 Gy (6 Gy/fraction, 2 times/week). 
The procedure of endotracheal brachytherapy implanted an 
applicator into the left main bronchus through bronchoscope 
to ensure that the distance was at least 2 cm from the top of the 
applicator to the lower bound of neoplasm. The patient was 
followed for almost 2 years without recurrence, as evidenced 
by CT and endoscopy (Fig. 1).
DISCUSSION
Primary airway lobular capillary hemangioma (LCH) is 
usually common in children and relatively rare in adults.1 The 
most common symptoms of patients with tracheal LCH are 
bleeding and airway obstruction. Accurate diagnosis requires 
CT and bronchoscopy.
The recurrence of skin and mucosal LCH after local 
therapy is a well-known concern. In this case, LCH was first 
treated with endoscopic electrocautery and argon plasma 
coagulation, but the patient subsequently remained symp-
tomatic. Then the patient underwent endotracheal high-dose 
rate brachytherapy and achieved long-term control of the 
disease. Although in recent years, there have been signifi-
cant advances in bronchoscopic intervention,2 endotracheal 
high-dose rate brachytherapy remains the preferred treat-
ment, especially for deep or large lesions. Compared with 
other treatments, brachytherapy offers distinctive biological 
and dosimetric advantages. First, brachytherapy can provide 
adequate doses to the lesions at the tracheal mucosa and 
submucosa. Second, the location of radioactive source can 
be adjusted for large lesions. Last but not least, high-dose 
brachytherapy has great advantage in the treatment of fibrous 
proliferation disease (such as keloids).3 At the most recent 
follow-up, the patient in our report was without any evidence 
of recurrence. Therefore, it can be concluded that for large 
and deep lesions, endotracheal high-dose rate brachytherapy 
offers great advantages.
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FIGURE 1. (A), Spiral CT scan: 
coronal view reconstruction, 
showing a pedunculated, densely 
enhancing mass, 1.5 × 2.0 
cm, arising from the left lateral 
wall of trachea (arrows). (B), 
Bronchoscopy: carina level and 
(C), Bronchoscopy: the left main 
bronchus level, showing a poly-
poid neoplasm in the lateral wall 
of the proximal left main bron-
chial (arrows). (D), Spiral CT scan: 
coronal-view reconstruction, show-
ing that the left main bronchus 
tumor disappeared after 2 years 
of endotracheal high-dose rate 
brachytherapy. (E), Bronchoscopy: 
carina level and (F), Bronchoscopy: 
the left main bronchus level, show-
ing the same result as the CT scan. 
CT, computed tomography.
FIGURE 3. Dose distribution of endotracheal brachytherapy 
in anteroposterior (A) and lateral (B) film.
FIGURE 2. The basic lesion is lobular hemangioma set in a 
fibromyxoid matrix, both acute and chronic inflammatory cells 
are scattered throughout the lesion (hematoxylin and eosin, 200).
